Evidence map›Paper›PMID 29449124›Full record

ArticleBioorganic & medicinal chemistry2018

Investigating PKA-RII specificity using analogs of the PKA:AKAP peptide inhibitor STAD-2.

N George Bendzunas, Sabrina Dörfler, Karolin Autenrieth, Daniela Bertinetti, Erik M F Machal, Eileen J Kennedy, Friedrich W Herberg

Open access · greenAbstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. GPharmacological reviews · 2021
    Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

N George BendzunasDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, College of Pharmacy, 240 W. Green St, Athens, GA 30602, USA.
Sabrina DörflerDepartment of Biochemistry, Kassel University, Heinrich-Plett-Strasse 40, Kassel 34132, Germany.
Karolin AutenriethDepartment of Biochemistry, Kassel University, Heinrich-Plett-Strasse 40, Kassel 34132, Germany.
Daniela BertinettiDepartment of Biochemistry, Kassel University, Heinrich-Plett-Strasse 40, Kassel 34132, Germany.
Erik M F MachalDepartment of Biochemistry, Kassel University, Heinrich-Plett-Strasse 40, Kassel 34132, Germany.
Eileen J KennedyDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, College of Pharmacy, 240 W. Green St, Athens, GA 30602, USA. Electronic address: ekennedy@uga.edu.
Friedrich W HerbergDepartment of Biochemistry, Kassel University, Heinrich-Plett-Strasse 40, Kassel 34132, Germany. Electronic address: herberg@uni-kassel.de.
University of Kassel · DEUniversity of Georgia · US

Funding

Probing the role of AKAPs in breast cancer using stapled peptide inhibitorsK22CA154600 · NCI · UNIVERSITY OF GEORGIA · PI KENNEDY, EILEEN J · 2011 to 2013
$571k
Targeted Inhibition of EGFR DimerizationR03CA188439 · NCI · UNIVERSITY OF GEORGIA · PI KENNEDY, EILEEN J · 2015 to 2016
$150k
NCI NIH HHS K22 CA154600NCI NIH HHS R03 CA188439
6 · The paper itself

Abstract

Generation of the second messenger molecule cAMP mediates a variety of cellular responses which are essential for critical cellular processes. In response to elevated cAMP levels, cAMP dependent protein kinase (PKA) phosphorylates serine and threonine residues on a wide variety of target substrates. In order to enhance the precision and directionality of these signaling events, PKA is localized to discrete locations within the cell by A-kinase anchoring proteins (AKAPs). The interaction between PKA and AKAPs is mediated via an amphipathic α-helix derived from AKAPs which binds to a stable hydrophobic groove formed in the dimerization/docking (D/D) domain of PKA-R in an isoform-specific fashion. Although numerous AKAP disruptors have previously been identified that can inhibit either RI- or RII-selective AKAPs, no AKAP disruptors have been identified that have isoform specificity for RIα versus RIβ or RIIα versus RIIβ. As a strategy to identify isoform-specific AKAP inhibitors, a library of chemically stapled protein-protein interaction (PPI) disruptors was developed based on the RII-selective AKAP disruptor, STAD-2. An alanine was substituted at each position in the sequence, and from this library it was possible to delineate the importance of longer aliphatic residues in the formation of a region which complements the hydrophobic cleft formed by the D/D domain. Interestingly, lysine residues that were added to both terminal ends of the peptide sequence to facilitate water solubility appear to contribute to isoform specificity for RIIα over RIIβ while having only weak interaction with RI. This work supports current hypotheses on the mechanisms of AKAP binding and highlights the significance of particular residue positions that aid in distinguishing between the RII isoforms and may provide insight into future design of isoform-selective AKAP disruptors.

Indexed as

A Kinase Anchor ProteinsAmino Acid SequenceCyclic AMP-Dependent Protein KinasesFluorescence PolarizationHumansKineticsPeptidesProtein BindingProtein Interaction MapsProtein IsoformsProtein Structure, SecondaryRecombinant ProteinsA Kinase Anchor ProteinsCyclic AMP-Dependent Protein KinasesPeptidesProtein IsoformsRecombinant ProteinsAKAPAKAP inhibitorConstrained peptideIsoform specificityPKAStapled peptide

Identifiers

PMID29449124
PMCPMC5844854
OpenAlexW2789803291

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.